Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deraco

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Tumori|June 11, 1999
N-nitroso compounds and Helicobacter pylori in the gastric remnantS Guadagni, M A Pistoia, G Amicucci, et al.
Tumori|August 9, 2003
[Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology]F Cavaliere, P Perri, C R Rossi, et al.
Oncology Reports|May 20, 2011
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancerM Santinami, F Cascinelli, A Chiti, et al.
The Journal of Surgical Research|January 8, 1999
N-Nitroso compounds, bacteria, and carcinoembryonic antigen in the gastric stumpS Guadagni, M A Pistoia, M Valenti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 14, 2010
Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)D Baratti, M Vaira, S Kusamura, et al.
Tumori|August 16, 2001
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical studyM Deraco, C R Rossi, E Pennacchioli, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
[Hyperthermic-antiblastic perfusion in the treatment of tumor of the extremities]F Di Filippo, F Cavaliere, M Anzà, et al.
Journal of Clinical Pharmacology|November 10, 1998
Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancerS Guadagni, K R Aigner, G Palumbo, et al.
Tumori|September 1, 1996
Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancerM Vaglini, F Cascinelli, A Chiti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 30, 2010
Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancerM Deraco, D Baratti, B Laterza, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Tumori|June 11, 1999
N-nitroso compounds and Helicobacter pylori in the gastric remnantS Guadagni, M A Pistoia, G Amicucci, et al.
Tumori|August 9, 2003
[Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology]F Cavaliere, P Perri, C R Rossi, et al.
Oncology Reports|May 20, 2011
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancerM Santinami, F Cascinelli, A Chiti, et al.
The Journal of Surgical Research|January 8, 1999
N-Nitroso compounds, bacteria, and carcinoembryonic antigen in the gastric stumpS Guadagni, M A Pistoia, M Valenti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 14, 2010
Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)D Baratti, M Vaira, S Kusamura, et al.
Tumori|August 16, 2001
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical studyM Deraco, C R Rossi, E Pennacchioli, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
[Hyperthermic-antiblastic perfusion in the treatment of tumor of the extremities]F Di Filippo, F Cavaliere, M Anzà, et al.
Journal of Clinical Pharmacology|November 10, 1998
Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancerS Guadagni, K R Aigner, G Palumbo, et al.
Tumori|September 1, 1996
Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancerM Vaglini, F Cascinelli, A Chiti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 30, 2010
Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancerM Deraco, D Baratti, B Laterza, et al.
Pageof 7